Violation Tracker Industry Summary Page

Industry: 
pharmaceuticals
Penalty Total since 2000: 
$33,123,998,360
Number of Records: 
470
Note: 
The total includes only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The penalty dollar total above is adjusted to account for the fact that the list of entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Duplicate penalty amounts are marked with an asterisk in the individual records list below.

Top 10 Parent CompaniesTotal Penalty $Number of Records
Pfizer$4,421,846,05547
GlaxoSmithKline$3,967,997,98213
Johnson & Johnson$3,430,247,32828
Merck$3,023,907,64042
Abbott Laboratories$2,338,807,42325
Teva Pharmaceutical Industries$2,198,128,58528
Eli Lilly$1,482,270,17613
Takeda Pharmaceutical$1,281,722,1706
Novartis$1,221,184,38622
Allergan$1,098,851,37413


Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summay page for that parent company.
Download results as CSV or XML
Company Parent Primary Offense Type Year Agency Penalty Amountsort icon
GlaxoSmithKline LLC GlaxoSmithKline off-label or unapproved promotion of medical products 2012 FDA $3,000,000,000
Pfizer Inc. Pfizer off-label or unapproved promotion of medical products 2009 FDA $2,300,000,000
Johnson & Johnson Johnson & Johnson off-label or unapproved promotion of medical products 2013 FDA $2,200,000,000
Abbott Laboratories Inc. Abbott Laboratories off-label or unapproved promotion of medical products 2012 FDA $1,500,000,000
Eli Lilly and Company Eli Lilly off-label or unapproved promotion of medical products 2009 FDA $1,415,000,000
Cephalon, Inc. Teva Pharmaceutical Industries consumer protection violation 2015 FTC $1,200,000,000
Merck, Sharp & Dohme Merck off-label or unapproved promotion of medical products 2011 FDA $950,000,000
TAP Pharmaceutical Products Inc. Takeda Pharmaceutical False Claims Act 2001 DOJ_CIVIL $875,000,000
Pfizer Inc. Pfizer False Claims Act 2016 DOJ_CIVIL $784,600,000
Amgen Inc. Amgen off-label or unapproved promotion of medical products 2012 FDA $762,000,000
SB Pharmco Puerto Rico Inc. GlaxoSmithKline drug or medical equipment safety violation 2010 FDA $750,000,000
Serono, S.A. Merck KGaA (EMD) off-label or unapproved promotion of medical products 2005 FDA $704,000,000
Merck & Company Merck False Claims Act 2008 DOJ_CIVIL $650,000,000
Allergan Inc. Allergan off-label or unapproved promotion of medical products 2010 FDA $600,000,000
Abbott Laboratories and CG Nutritionals Abbott Laboratories False Claims Act 2003 DOJ_CIVIL $600,000,000
AstraZeneca LP AstraZeneca off-label or unapproved promotion of medical products 2010 FDA $520,000,000
Bristol-Myers Squibb Company Bristol-Myers Squibb off-label or unapproved promotion of medical products 2007 DOJ_CIVIL $515,000,000
Ranbaxy USA Inc. Sun Pharmaceuticals drug or medical equipment safety violation 2013 FDA $500,000,000
Schering-Plough Corporation Merck drug or medical equipment safety violation 2002 DOJ_CIVIL $500,000,000
Wyeth Pharmaceuticals Inc. Pfizer off-label or unapproved promotion of medical products 2013 FDA $490,900,000
Mylan Inc. Mylan False Claims Act 2017 DOJ_CIVIL $465,000,000
Purdue Frederick Company Inc. Purdue Pharma False Claims Act 2007 USAO $461,900,000
Schering-Plough Corporation Merck off-label or unapproved promotion of medical products 2006 USAO $435,000,000
Warner-Lambert Pfizer off-label or unapproved promotion of medical products 2004 FDA $430,000,000
Cephalon Inc Teva Pharmaceutical Industries off-label or unapproved promotion of medical products 2008 FDA $425,000,000
Novartis Pharmaceuticals Corporation Novartis off-label or unapproved promotion of medical products 2010 FDA $422,500,000
Janssen Pharmaceuticals, Inc. Johnson & Johnson off-label or unapproved promotion of medical products 2013 USAO $410,000,000
Novartis Pharmaceuticals Novartis kickbacks and bribery 2015 USAO $390,000,000
Actelion Pharmaceuticals US, Inc. Johnson & Johnson False Claims Act 2018 DOJ_CIVIL $360,000,000
AstraZeneca Pharmaceuticals LP AstraZeneca False Claims Act 2003 DOJ_CIVIL $354,900,000
Shire Pharmaceuticals LLC Takeda Pharmaceutical False Claims Act 2017 DOJ_CIVIL $350,000,000
Schering-Plough Corporation Merck kickbacks and bribery 2004 DOJ_CIVIL $345,000,000
Bristol-Myers Squibb Bristol-Myers Squibb fraud 2005 USAO $300,000,000
Teva Pharmaceutical Industries Ltd Teva Pharmaceutical Industries Foreign Corrupt Practices Act 2016 DOJ_CRIMINAL $283,177,348
Dey Inc. Mylan False Claims Act 2010 DOJ_CIVIL $280,000,000
Roxane Laboratories Inc. Hikma Pharmaceuticals False Claims Act 2010 DOJ_CIVIL $280,000,000
Celgene Corp. Celgene False Claims Act 2017 USAO $280,000,000
Teva Pharmaceutical Industries Limited Teva Pharmaceutical Industries Foreign Corrupt Practices Act 2016 SEC $236,000,000
Insys Therapeutics Insys Therapeutics False Claims Act 2019 DOJ_CIVIL $225,000,000
United Therapeutics Corporation United Therapeutics False Claims Act 2017 DOJ_CIVIL $210,000,000
Elan Corporation PLC Perrigo off-label or unapproved promotion of medical products 2010 FDA $203,000,000
Endo Health Solutions Inc. Endo International off-label or unapproved promotion of medical products 2014 FDA $192,700,000
Aventis Pharmaceuticals Inc. Sanofi False Claims Act 2007 DOJ_CIVIL $190,000,000
Novartis Corporation Novartis employment discrimination 2010 private lawsuit-federal $175,000,000
Forest Pharmaceuticals Inc. Allergan off-label or unapproved promotion of medical products 2011 FDA $164,000,000
GlaxoSmithKline GlaxoSmithKline False Claims Act 2005 DOJ_CIVIL $150,000,000
Bristol-Myers Squibb Company Bristol-Myers Squibb accounting fraud or deficiencies 2004 SEC $150,000,000
Forest Pharmaceuticals Inc. Allergan False Claims Act 2010 USAO $149,000,000
Abbott Laboratories Inc. Abbott Laboratories False Claims Act 2010 DOJ_CIVIL $126,500,000
Warner Chilcott PLC Allergan off-label or unapproved promotion of medical products 2015 FDA $125,000,000
King Pharmaceuticals Pfizer False Claims Act 2005 DOJ_CIVIL $124,000,000
Mylan Pharmaceuticals and UDL Laboratories Mylan False Claims Act 2009 DOJ_CIVIL $118,000,000
Sanofi-Aventis U.S. Inc. Sanofi False Claims Act 2012 DOJ_CIVIL $109,000,000
Mylan Laboratories, Inc. Mylan consumer protection violation 2000 FTC $100,000,000
Mallinckrodt ARD Inc Mallinckrodt price-fixing or anti-competitive practices 2017 FTC $100,000,000
Astellas Pharma US Inc. Astellas Pharma False Claims Act 2019 DOJ_CIVIL $100,000,000
Novartis Novartis wage and hour violation 2012 private lawsuit-federal $99,000,000
Aventis Pharmaceutical Inc. Sanofi False Claims Act 2009 DOJ_CIVIL $95,500,000
Boehringer Ingelheim Pharmaceuticals Inc. Boehringer Ingelheim off-label or unapproved promotion of medical products 2012 FDA $95,000,000
Scios Inc. Johnson & Johnson off-label or unapproved promotion of medical products 2011 FDA $85,000,000
Depuy Orthopaedics Inc. Johnson & Johnson False Claims Act 2007 USAO $84,700,000
Ortho-McNeil Pharmaceutical LLC Johnson & Johnson off-label or unapproved promotion of medical products 2010 FDA $81,000,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation Novartis off-label or unapproved promotion of medical products 2010 FDA $72,500,000
Genentech Inc. Roche False Claims Act 2016 DOJ_CIVIL $67,000,000
OSI Pharmaceuticals LLC Astellas Pharma False Claims Act 2016 DOJ_CIVIL $67,000,000
LifeScan Inc. Johnson & Johnson drug or medical equipment safety violation 2000 USAO $60,000,000
Novo Nordisk Inc. Novo Holdings A/S False Claims Act 2017 DOJ_CIVIL $58,650,000
Jazz Pharmaceuticals plc Jazz Pharmaceuticals False Claims Act 2019 DOJ_CIVIL $57,000,000
Shire Pharmaceuticals LLC Takeda Pharmaceutical off-label or unapproved promotion of medical products 2014 FDA $56,500,000
Pfizer Inc. Pfizer drug or medical equipment safety violation 2012 FDA $55,000,000
Salix Pharmaceuticals Inc. Bausch Health kickbacks and bribery 2016 USAO $54,000,000
Lundbeck LLC Lundbeck False Claims Act 2019 DOJ_CIVIL $52,600,000
Merck & Co., Inc. Merck benefit plan administrator violation 2011 private lawsuit-federal $49,500,000
Pfizer Corporation Pfizer False Claims Act 2002 DOJ_CIVIL $49,000,000
Johnson & Johnson Johnson & Johnson Foreign Corrupt Practices Act 2011 SEC $48,600,000
SmithKline Beecham GlaxoSmithKline False Claims Act 2003 DOJ_CIVIL $47,000,000
AstraZeneca LP AstraZeneca False Claims Act 2015 DOJ_CIVIL $46,500,000
Par Pharmaceutical Companies Inc. Endo International off-label or unapproved promotion of medical products 2013 FDA $45,000,000
Serono Laboratories Inc. Merck KGaA (EMD) False Claims Act 2011 DOJ_CIVIL $44,300,000
Alpharma Inc. Pfizer False Claims Act 2010 DOJ_CIVIL $42,500,000
Kos Pharmaceuticals AbbVie kickbacks and bribery 2010 FDA $41,500,000
Briston-Myers Squibb Bristol-Myers Squibb benefit plan administrator violation 2005 private lawsuit-federal $41,220,000
Daiichi Sankyo Inc. Daiichi Sankyo False Claims Act 2015 DOJ_CIVIL $39,000,000
Endo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals Endo International drug or medical equipment safety violation 2015 USAO $39,000,000
Forest Laboratories and Forest Pharmaceuticals Allergan False Claims Act 2016 DOJ_CIVIL $38,000,000
Eli Lilly and Company Eli Lilly off-label or unapproved promotion of medical products 2005 FDA $36,000,000
Mallinckrodt LLC Mallinckrodt Controlled Substances Act violation 2017 DEA $35,000,000
Aegerion Pharmaceuticals Inc. Novelion Therapeutics drug or medical equipment safety violation 2017 DOJ_CIVIL $35,000,000
UCB Inc. UCB off-label or unapproved promotion of medical products 2011 FDA $34,000,000
Alere Inc. Abbott Laboratories False Claims Act 2018 DOJ_CIVIL $33,200,000
Genzyme Corporation Sanofi drug or medical equipment safety violation 2015 FDA $32,587,439
Eli Lilly and Company Eli Lilly Foreign Corrupt Practices Act 2012 SEC $29,398,734
Ethex Corporation KV Pharmaceutical drug or medical equipment safety violation 2010 FDA $27,600,000
Teva Pharmaceuticals USA Inc. and IVAX LLC Teva Pharmaceutical Industries False Claims Act 2014 DOJ_CIVIL $27,600,000
Schering-Plough Merck False Claims Act 2004 DOJ_CIVIL $27,000,000
Pfizer Inc. Pfizer Foreign Corrupt Practices Act 2012 SEC $26,339,944
Sanofi Sanofi Foreign Corrupt Practices Act 2018 SEC $25,200,000
McNeil-PPC Inc. Johnson & Johnson drug or medical equipment safety violation 2015 FDA $25,000,000
Novo Nordisk Inc. Novo Holdings A/S off-label or unapproved promotion of medical products 2011 FDA $25,000,000
Novartis AG Novartis Foreign Corrupt Practices Act 2016 SEC $25,000,000
Abbott Laboratories Abbott Laboratories off-label or unapproved promotion of medical products 2018 USAO $25,000,000
Download results as CSV or XML